Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Medical School

University of San Francisco

San Francisco, CA

Internship

Boston Combined Residency Program (BCRP)

Boston, MA

Residency

Boston Combined Residency Program (BCRP)

Boston, MA

Fellowship

Dana-Farber Cancer Institute

Boston, MA

Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Hematology-Oncology)

Professional History

Dr. Feraco received an MD degree from the University of California, San Francisco (UCSF) and a Master’s of Medical Science in Medical Education from Harvard Medical School. She completed her clinical training in pediatrics in the Boston Combined Residency Program (BCRP) and her pediatric hematology/oncology fellowship training at Dana-Farber Cancer Institute and Boston Children’s Hospital. Dr. Feraco’s clinical expertise is in pediatric leukemias and lymphomas with a particular emphasis on Hodgkin lymphoma. Dr. Feraco is also a medical educator and serves as Associate Program Director for the Pediatric Hematology/Oncology Fellowship at Dana-Farber Cancer Institute and Boston Children’s Hospital. Dr. Feraco studies interprofessional collaboration and communication among pediatric oncology teams and pediatric palliative care teams. Ultimately, Dr. Feraco seeks to leverage meaningful interprofessional teamwork and high-quality communication to enhance disease outcomes and quality of life for children with cancer. Dr. Feraco was awarded a Junior Faculty Career Development Award by the National Palliative Care Research Center in 2017 and is a 2020 Sojourns Scholar, awarded by the Cambia Foundation.

Publications

  1. Psychosocial Experiences of African American Parents of Children With Cancer. Pediatrics. 2025 May 22. View Abstract

  2. Illness Uncertainty in Parents of Children With Cancer-An Exploratory Analysis to Inform Intervention Development. Pediatr Blood Cancer. 2025 Jul; 72(7):e31726. View Abstract

  3. Spindle lesions in the thyroid: a cytological and histological review. Virchows Arch. 2025 Apr 11. View Abstract

  4. Enabling Inclusive Psychosocial Research Strategies Among African American Parents of Children With Cancer. J Pain Symptom Manage. 2025 May; 69(5):e414-e416. View Abstract

  5. Uncovering Structurally Differential Care: Pediatric Oncology Nurses' Perspectives Caring for African American Families. J Pain Symptom Manage. 2025 May; 69(5):455-464. View Abstract

  6. Education Needs for Pediatrics Residency Training: Bringing Palliative Care to the Table. J Pediatr. 2025 Apr; 279:114463. View Abstract

  7. Diagnostic and Predictive Immunocytochemistry in Head and Neck Lesions. Acta Cytol. 2025; 69(1):77-103. View Abstract

  8. Characterisation of metastases in parotid gland lesions: clinical and cytological insights. J Clin Pathol. 2024 Nov 28. View Abstract

  9. Teaching pediatric cardiology fellows to communicate serious news: a pilot study. BMC Med Educ. 2024 Oct 07; 24(1):1092. View Abstract

  10. Clinical and immunophenotype correlating with response to immunotherapy in paediatric patients with primary liver carcinoma. A case series. EBioMedicine. 2024 Jun; 104:105147. View Abstract

  11. Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90. Blood Adv. 2023 11 14; 7(21):6665-6667. View Abstract

  12. A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. Cancer Med. 2023 06; 12(12):13300-13308. View Abstract

  13. 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. Hematol Oncol. 2023 Jun; 41 Suppl 2:73-75. View Abstract

  14. Adaptation of the Day100 Talk communication intervention for Spanish-speaking families of children with cancer. Pediatr Blood Cancer. 2023 03; 70(3):e30101. View Abstract

  15. Normalization of Symptoms in Advanced Child Cancer: The PediQUEST-Response Case Study. J Pain Symptom Manage. 2022 04; 63(4):548-562. View Abstract

  16. Pediatric palliative care has a place everywhere. Pediatr Blood Cancer. 2022 03; 69(3):e29476. View Abstract

  17. Are we undermining the value of palliative care through advanced cancer clinical trial consent language? Cancer. 2021 06 15; 127(12):1954-1956. View Abstract

  18. Feasibility and acceptability of the "Day 100 Talk": An interdisciplinary communication intervention during the first six months of childhood cancer treatment. Cancer. 2021 04 01; 127(7):1134-1145. View Abstract

  19. Parent Perceptions of Team-Delivered Care for Children With Advanced Cancer: A Report From the PediQUEST Study. J Pain Symptom Manage. 2020 10; 60(4):811-817. View Abstract

  20. Cancer Treatment-Related Infertility: A Critical Review of the Evidence. JNCI Cancer Spectr. 2019 Mar; 3(1):pkz008. View Abstract

  21. "What if?": Addressing uncertainty with families. Pediatr Blood Cancer. 2019 06; 66(6):e27699. View Abstract

  22. Integrating palliative and oncology care: paediatric considerations. Lancet Oncol. 2018 11; 19(11):e572-e573. View Abstract

  23. Intimate Partner Relationships, Work-Life Factors, and Their Associations With Burnout Among Partnered Pediatric Residents. Acad Pediatr. 2019 04; 19(3):263-268. View Abstract

  24. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol. 2018 05; 19(5):705-714. View Abstract

  25. Development of the "Day 100 Talk": Addressing existing communication gaps during the early cancer treatment period in childhood cancer. Pediatr Blood Cancer. 2018 06; 65(6):e26972. View Abstract

  26. Discussions Across Disagreement: The Role for Simulation. J Palliat Med. 2017 10; 20(10):1050-1051. View Abstract

  27. Pediatric Resident Burnout and Attitudes Toward Patients. Pediatrics. 2017 Mar; 139(3). View Abstract

  28. Tumor Talk and Child Well-Being: Perceptions of "Good" and "Bad" News Among Parents of Children With Advanced Cancer. J Pain Symptom Manage. 2017 05; 53(5):833-841. View Abstract

  29. Reliability of Verbal Handoff Assessment and Handoff Quality Before and After Implementation of a Resident Handoff Bundle. Acad Pediatr. 2016 08; 16(6):524-31. View Abstract

  30. The Creation of Standard-Setting Videos to Support Faculty Observations of Learner Performance and Entrustment Decisions. Acad Med. 2016 Feb; 91(2):204-9. View Abstract

  31. Communication Skills Training in Pediatric Oncology: Moving Beyond Role Modeling. Pediatr Blood Cancer. 2016 Jun; 63(6):966-72. View Abstract

  32. Changes in medical errors after implementation of a handoff program. N Engl J Med. 2014 Nov 06; 371(19):1803-12. View Abstract

  33. I-pass, a mnemonic to standardize verbal handoffs. Pediatrics. 2012 Feb; 129(2):201-4. View Abstract

  34. Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology. Am J Cardiol. 2009 Nov 01; 104(9):1280-4. View Abstract

  35. The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs. Hematol Oncol Clin North Am. 2006 Aug; 20(4):797-809. View Abstract
BESbswy